NK Cell TRAIL Eliminates Immature Dendritic Cells in Vivo and Limits Dendritic Cell Vaccination Efficacy

Journal of Immunology

Volumn 172, Issue 1, 2004, Pages 123-129

  Hayakawa, Yoshihiro ^a   Screpanti, Valentina ^b   Yagita, Hideo ^c   Grandien, Alf ^b   Ljunggren, Hans Gustaf ^b   Smyth, Mark J ^a   Chambers, Benedict J ^b,d  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER; CANCER THERAPY; CELL MATURATION; CELL SURVIVAL; CELLULAR IMMUNITY; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; IMMUNIZATION; IMMUNOREGULATION; IN VIVO STUDY; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; T LYMPHOCYTE; TUMOR IMMUNITY;

EID: 0347364696     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.172.1.123     Document Type: Article

References (54)

1. Banchereau, J., and R. M. Steinman. 1998. Dendritic cells and the control of immunity. Nature 392:245.
2. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18:767.
3. Fong, L., and E. G. Engleman. 2000. Dendritic cells in cancer immunotherapy. Annu. Rev. Immunol. 18:245.
4. Steinman, R. M., and M. Dhodapkar. 2001. Active immunization against cancer with dendritic cells: the near future. Int. J. Cancer 94:459.
5. + cytolytic T cells by suppressing of or eliminating dendritic cells. J. Immunol. 136:3567.
6. Chambers, B. J., M. Salcedo, and H. G. Ljunggren. 1996. Triggering of natural killer cells by the costimulatory molecule CD80 (B7-1). Immunity 5:311.
7. Geldhof, A. B., M. Moser, L. Lespagnard, K. Thielemans, and P. De Baetselier. 1998. Interleukin-12-activated natural killer cells recognize B7 costimulatory molecules on tumor cells and autologous dendritic cells. Blood 91:196.
8. Carbone, E., G. Terrazzano, G. Ruggiero, D. Zanzi, A. Ottaiano, C. Manzo, K. Karre, and S. Zappacosta. 1999. Recognition of autologous dendritic cells by human NK cells. Eur. J. Immunol. 29:4022.
9. Parajuli, P., Y. Nishioka, N. Nishimura, S. M. Singh, M. Hanibuchi, H. Nokihara, H. Yanagawa, and S. Sone. 1999. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing. J. Leukocyte Biol. 65:764.
10. Wilson, J. L., L. C. Heffler, J. Charo, A. Scheynius, M. T. Bejarano, and H. G. Ljunggren. 1999. Targeting of human dendritic cells by autologous NK cells. J. Immunol. 163:6365.
11. Gerosa, F., B. Baldani-Guerra, C. Nisii, V. Marchesini, G. Carra, and G. Trinchieri. 2002. Reciprocal activating interaction between natural killer cells and dendritic cells. J. Exp. Med. 195:327.
12. Piccioli, D., S. Sbrana, E. Melandri, and N. M. Valiante. 2002. Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J. Exp. Med. 195:335.
13. Ferlazzo, G., M. L. Tsang, L. Moretta, G. Melioli, R. M. Steinman, and C. Munz. 2002. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J. Exp. Med. 195:343.
14. + T cells. Cell 71:1205.
15. Kagi, D., B. Ledermann, K. Burki, P. Seiler, B. Odermatt, K. J. Olsen, E. R. Podack, R. M. Zinkernagel, and H. Hengartner. 1994. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31.
16. Cretney, E., K. Takeda, H. Yagita, M. Glaccum, J. J. Peschon, and M. J. Smyth. 2002. Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice. J. Immunol. 168:1356.
17. Smyth, M. J., E. Cretney, K. Takeda, R. H. Wiltrout, L. M. Sedger, N. Kayagaki, H. Yagita, and K. Okumura. 2001. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) contributes to interferon γ-dependent natural killer cell protection from tumor metastasis. J. Exp. Med. 193:661.
18. Norbury, C. C., B. J. Chambers, A. R. Prescott, H. G. Ljunggren, and C. Watts. 1997. Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells. Eur. J. Immunol. 27:280.
19. Sandberg, J. K., P. Grufman, E. Z. Wolpert, L. Franksson, B. J. Chambers, and K. Karre. 1998. Superdominance among immunodominant H-2Kb-restricted epitopes and reversal by dendritic cell-mediated antigen delivery. J. Immunol. 160:3163.
20. Smyth, M. J., J. M. Kelly, A. G. Baxter, H. Korner, and J. D. Sedgwick. 1998. An essential role for tumor necrosis factor in natural killer cell-mediated tumor rejection in the peritoneum. J. Exp. Med. 188:1611.
21. Riccardi, C., P. Puccetti, A. Santoni, and R. B. Herberman. 1979. Rapid in vivo assay of mouse natural killer cell activity. J. Natl. Cancer Inst. 63:1041.
22. Ljunggren, H. G., and K. Kärre. 1985. Host resistance directed selectively against H-2-deficient lymphoma variants: analysis of the mechanism. J. Exp. Med. 162:1745.
23. Smyth, M. J., K. Takeda, Y. Hayakawa, J. J. Peschon, M. R. van den Brink, and H. Yagita. 2003. Nature's TRAIL: on a path to cancer immunotherapy. Immunity 18:1.
24. Leverkus, M., H. Walczak, A. McLellan, H. W. Fries, G. Terbeck, E. B. Brocker, and E. Kampgen. 2000. Maturation of dendritic cells leads to up-regulation of cellular FLICE-inhibitory protein and concomitant down-regulation of death ligand-mediated apoptosis. Blood 96:2628.
25. L. Cancer Immunol. Immunother. 51:139.
26. -/- mice. Nat. Immun. 4:255.
27. Cretney E., A. P. Uldrich, S. P. Berzins, A. Strasser, D. I. Godfrey, and M. J. Smyth. 2003. Normal thymocyte negative selection in TRAIL-deficient mice. JEM 198:491.
28. Kagi, D., P. Seiler, J. Pavlovic, B. Ledermann, K. Burki, R. M. Zinkemagel, and H. Hengartner. 1995. The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. Eur. J. Immunol. 25:3256.
29. Van den Brock, M. E., D. Kagi, F. Ossendorp, R. Toes, S. Vamvakas, W. K. Lutz, C. J. Melief, R. M. Zinkernagel, and H. Hengartner. 1996. Decreased tumor surveillance in perforin-deficient mice. J. Exp. Med. 184:1781.
30. Smyth, M. J., K. Y. Thia, E. Cretney, J. M. Kelly, M. B. Snook, C. A. Forbes, and A. A. Scalzo. 1999. Perforin is a major contributor to NK cell control of tumor metastasis. J. Immunol. 162:6658.
31. Street, S. E., E. Cretney, and M. J. Smyth. 2001. Perforin and interferon-γ activities independently control tumor initiation, growth, and metastasis. Blood 97:192.
32. Taylor, M. A., B. Ward, J. D. Schatzle, and M. Bennett. 2002. Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts. Eur. J. Immunol. 32:793.
33. Zamai, L., M. Ahmad, I. M. Bennett, L. Azzoni, E. S. Alnemri, and B. Perussia. 1998. Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188:2375.
34. Rosen, D., J. H. Li, S. Keidar, I. Markon, R. Orda, and G. Berke. 2000. Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1). J. Immunol. 164:3229.
35. Taylor, M. A., P. M. Chaudhary, J. Klem, V. Kumar, J. D. Schatzle, and M. Bennett. 2001. Inhibition of the death receptor pathway by cFLIP confers partial engraftment of MHC class 1-deficient stem cells and reduces tumor clearance in perforin-deficient mice. J. Immunol. 167:4230.
36. Screpanti, V., R. P. Wallin, H. G. Ljunggren, and A. Grandien. 2001. A central role for death receptor-mediated apoptosis in the rejection of tumors by NK cells. J. Immunol. 167:2068.
37. Takeda, K., Y. Hayakawa, M. J. Smyth, N. Kayagaki, N. Yamaguchi, S. Kakuta, Y. Iwakura, H. Yagita, and K. Okumura. 2001. Involvement of tumor necrosis factor-related apoptosis-inducing ligand in surveillance of tumor metastasis by liver natural killer cells. Nat. Med. 7:94.
38. Takeda, K., M. J. Smyth, E. Cretney, Y. Hayakawa, N. Kayagaki, H. Yagita, and K. Okumura. 2002. Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development. J. Exp. Med. 195:161.
39. Rescigno, M., V. Piguet, B. Valzasina, S. Lens, R. Zubler, L. French, V. Kindler, J. Tschopp, and P. Ricciardi-Castagnoli. 2000. Fas engagement induces the maturation of dendritic cells (DCs), the release of interleukin (IL)-1β, and the production of interferon γ in the absence of IL-12 during DC-T cell cognate interaction: a new role for Fas ligand in inflammatory responses. J. Exp. Med. 192:1661.
40. + T cells in vivo: implications for adaptive immunotherapy. Eur. J. Immunol. 31:1772.
41. Trapani, J. A., and M. J. Smyth. 2002. Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2:735.
42. + T cell expansion and mortality in vaccinated perforin-deficient mice. Immunity 18:463.
43. Strbo, N., S. Oizumi, V. Sotosek-Tokmadzic, and E. R. Podack. 2003. Perforin is required for innate and adaptive immunity induced by heat shock protein gp96. Immunity 18:381.
44. Moser, M., and K. M. Murphy. 2000. Dendritic cell regulation of TH1-TH2 development. Nat. Immun. 1:199.
45. Fernandez, N. C., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:405.
46. Stoll, S., J. Delon, T. M. Brotz, and R. N. Germain. 2002. Dynamic imaging of T cell-dendritic cell interactions in lymph nodes. Science 296:1873.
47. Chambers, B. J., and H. G. Ljunggren. 1999. NK cells. In Denritic Cells. M. T. Lotze and A. W. Thomson, eds. Academic Press, San Diego, p. 257.
48. Shi, F., H. G. Ljunggren, and N. Sarvetnick. 2001. Innate immunity and autoimmunity: from self-protection to self-destruction. Trends Immunol. 22:97.
49. Zitvogel, L. 2002. Dendritic and natural killer cells cooperate in the control/switch of innate immunity. J. Exp. Med. 195:F9.
50. Moser, M. 2003. Dendritic cells in immunity and tolerance: do they display opposite functions? Immunity 19:5.
51. Abruzzo, L. V., C. A. Mullen, and D. A. Rowley. 1986. Immunoregulation by natural killer cells. Cell. Immunol. 98:266.
52. Flodstrom, M., F. D. Shi, N. Sarvetnick, and H. G. Ljunggren. 2002. The natural killer cell: friend or foe in autoimmune disease? Scand. J. Immunol. 55:432.
53. Buentke, E., L. C. Heffler, J. L. Wilson, R. P. Wallin, C. Lofman, B. J. Chambers, H. G. Ljunggren, and A. Scheynius. 2002. Natural killer and dendritic cell contact in lesional atopic dermatitis skin-Malassezia-influenced cell interaction. J. Invest. Dermatol. 119:850.
54. Smyth, M. J., Y. Hayakawa, K. Takeda, and H. Yagita. 2002. New aspects of natural-killer-cell surveillance and therapy of cancer. Nat. Rev. Cancer 2:850.